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Abstract 
Objective: To analyze whether the FokI polymorphism (rs228570) present in the vitamin D receptor gene 
in type 2 diabetics is related to chronic periodontitis's clinical status and evaluates the influence of chronic 
periodontitis on the perception of quality of life. Material and Methods: It is a clinical and laboratory 
study, composed of a sample of 59 individuals with previous diagnosis of type 2 Diabetes Mellitus and 
chronic periodontitis, of both sexes. On clinical examination, socio-epidemiological data and quality of life of 
patients with the Oral Health Impact Profile (OHIP-14) were recorded and a periogram was performed.  
Subsequently, saliva was collected spontaneously in sterile Falcon tubes (15 ml) and stored in the freezer at 
-20 °C. The purification of the genetic material was done with a PROMEGA kit (Wizard®), and the 
polymorphism studied was FokI (rs228570), found in the vitamin D receptor promoting region, with rs: 
228570. After extraction of saliva DNA and purification, genotyping was performed by real-time PCR using 
specific allele probes (TaqMan® System). Results: The polymorphism of the vitamin D receptor gene was 
not positively associated with the severity and clinical characteristics of periodontitis, but suggested a 
relationship with the extent of the disease. Periodontitis also had no positive association with patients' 
perception of quality of life. Conclusion: The perception of quality of life of patients with chronic 
periodontitis and type 2 diabetes mellitus was compromised by the systemic condition, secondary to oral 
health, although some dimensions of OHIP-14 have been more frequently mentioned, such as psychological 
discomfort, physical pain and physical disability. 
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Introduction 
Diabetes mellitus is a group of chronic metabolic diseases in which insulin production by pancreatic 
beta cells is deficient or the non-beneficial use of this hormone leads to hyperglycemia. It is estimated that the 
number of people in the world affected with diabetes may increase from 382 million to 592 million between 
2013 and 2035. There are several types of diabetes mellitus, being classified into two main types: type 1 (DM1) 
and type 2 (DM2) [1]. 
The causal origin of DM2 is related to several factors such as physical inactivity, excess body weight 
and poor eating habits, characterized by systemic inflammation and poor regulation of glucose levels [2]. 
Individuals with DM2 constitute 90% of all diabetic patients [3], and this chronic condition is recognized as an 
important risk factor for the prevalence and severity of periodontal disease (DP) [4]. 
Periodontitis develops due to an imbalance between the bacterial challenge and the host's immune 
response, which generates inflammation, destruction of connective tissue, and bone tissue remodeling. It has a 
multifactorial etiology; however, recent findings suggest that genetic factors [5] and vitamin D [6] influence 
their disposition. 
In recent years, it has been discovered that vitamin D can affect periodontal status since it acts on 
bone homeostasis of calcium and is an anti-inflammatory agent that inhibits the expression of immune cell 
cytokines causing monocytes / macrophages to secrete molecules that have a strong antibiotic effect [6]. For 
all these reasons, this vitamin affects directly the pathogenesis induced by Porphyromonas gingivalis [7], 
becoming a protective factor against DP progression [8]. 
Vitamin D is known to express its genomic action through its receptor (VDR), which shows numerous 
polymorphisms rs731236 (TaqI), rs7975232 (ApaI), rs1544410 (BsmI) and rs2228570 (FokI) that affect the 
functional activity of the VDR protein in PD [9]. 
However, of all these polymorphisms, only one specific can result in differences in the amino acid 
sequence of the VDR protein, changing its structure, FokI [10], and its research may perhaps serve in the 
future as a genetic biomarker of periodontitis [11]. Thus, the early identification of these risk indicators for the 
development of DP may prove to be essential to signal the individuals most predisposed to their development 
and institute personalized therapies and more effective preventive strategies [12]. 
However, the epidemiological evidence on the relationship between VDR, its polymorphisms, 
especially FokI, and periodontitis are inconsistent, requiring more detailed work, which could bring important 
contributions to its understanding [13]. 
Periodontitis, too, is often related to tooth mobility and gingival recession, which can alter the smile's 
aesthetics and, negatively, affect self-esteem, decreasing quality of life. However, there is no significant data 
regarding this perception in Brazilian patients with diabetes [14]. 
It is essential to understand how people perceive their oral health and the implications for everyday 
life [15] and one of the most used indexes to assess the impact of oral health on quality of life is the Oral 
Health Impact Profile (OHIP-14), which was developed to obtain information about the nature and extent of 
the functional, social and psychological impact on dental research [16]. The higher the total OHIP-14 score, 
the greater the oral problems perceived by the patient and the greater their reflexes on quality of life [14]. 
From this perspective, this study investigated whether the FokI polymorphism (rs228570) present in 
the vitamin D receptor (VDR) gene in type 2 diabetics is related to the clinical status of chronic periodontitis in 
these patients and to evaluate the influence of periodontitis on perception of quality of life. 
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Material and Methods 
Study Design and Sample 
This is a clinical and laboratory study, composed of a sample of 59 individuals with DM2 following 
the parameters of the Brazilian Diabetes Society: (1) Symptoms of polyuria, polydipsia and weight loss plus 
casual blood glucose ≥ 200 mg/d; (2) Fasting blood glucose ≥ 126 mg/d (7 mmol/l); (3) Blood glucose after 
overloading 75 g of glucose in 2 hours ≥ 200 (A) 1.2 mg / d; (4) Glycosylated Hemoglobin (HbA1C) greater 
than or equal to 6.5% and insulin resistance) [17]. 
The parameters of chronic periodontitis followed the guidelines of the American Academy of 
Periodontics (periodontal pocket, bleeding and clinical insertion level greater than 3mm) [18], for both sexes. 
The individuals' data collection was carried out in the post-graduate dental clinic of the Dentistry Course of 
the Federal University of Pernambuco (UFPE) and the Endocrinology Clinic of the Hospital Agamenon 
Magalhães (HAM), both located in the city of Recife, Brazil.  
The sample selection followed the following inclusion criteria: having DM2, having a clinical 
diagnosis of chronic periodontitis, having at least 8 (eight) natural teeth, accepting to participate in the 
research by signing the informed consent form and being at least 35 years old [19]. The exclusion criteria 
were: being a smoker, being pregnant or breastfeeding, having undergone periodontal treatment or using 
antibiotics in the last 6 months, using anti-inflammatory drugs in a chronic way. 
 
Clinical Examination 
Before starting the clinical examination, socio-epidemiological data on age, sex, income, education, 
marital status, smoking, type of diabetes, use of medications (including insulin) and time with diabetes were 
recorded, as well as data on the quality of life of patients using the OHIP-14. 
A periogram containing data on probing depth (PD) and Clinical attachment level (CAL) was filled 
out. Data on visible plaque and bleeding on probing were also collected to verify the respective indices. Six 
sites were probed for each tooth: mesio-vestibular, mid-vestibular, disto-vestibular, mesio-lingual, mid-lingual 
and disto-lingual. This examination was carried out with artificial light and using as instruments: odontoscope 
and millimeter-periodontal probe of the North Carolina University type and Trinity® brand, in addition to 
personal protective equipment (hat, mask, gloves, glasses, lab coat). 
 
Collection of Biological Material and DNA Isolation 
After the clinical examination, saliva was collected in sterile Falcon tubes (15 ml), asking the 
individual to spit for three minutes [20]. The collected material was placed in a thermal box with recyclable 
ice and taken to the Laboratory of Molecular Biology of the Graduate School of Dentistry at UFPE for storage 
in a freezer at a temperature of -20°C, for subsequent isolation of the genetic material. The isolation of 
deoxyribonucleic acid (DNA) was performed using the PROMEGA genomic DNA purification kit (Wizard®, 
Promega Corporation, Madison, WI, USA), following the manufacturer's protocol for blood samples. The 
material was quantified using nanodrop (Thermo Fisher Scientific Inc., Waltham, MA, USA), and kept at -20ºC 
until the realization of the Polymerase Chain Reaction (PCR) in real-time. 
 
SNPS Selection and Real-Time PCR Genotyping 
The selection of SNPs for the study was based on the following criteria: MAF (Minim Allele 
Frequency) values, functional impact of the variant and previous associations of the variants with periodontitis, 
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DM2 and/or inflammatory diseases in other populations. Variants with MAF values greater than 0.1 (10%) 
were selected in the Caucasian (Utah Residents with Northern and Western European Ancestry - CEU) and 
African (Yoruba in Ibadan, Nigeria - YRI) populations, which contributed to the formation of the Brazilian 
population. The MAF values for the different polymorphisms in the population were obtained from public 
databases such as: HapMap [21] and 1000 genomes project [22]. For the VDR gene, the selected variant was: 
rs2228570 G/A (FOK 1), located in the coding promoter region of chromosome 12q13.1, at position 4787912 
[23]. Genotyping was performed by real-time PCR using specific allele probes (TaqMan®, Applied 
Biosystems, Foster City, CA, USA) and the ABI 7500 thermocycler (Applied Biosystems, Foster City, CA, 
USA) [24]. To detect the genotypes of each SNPs of the studied genes, a reaction with a total volume of 5 µl 
was used for each variant, containing approximately 1µl of template DNA per reaction (with a concentration of 
25ng/µl), 1.25µl of water, 2.5µl of TaqMan® Universal PCR Master Mix (Applied Biosystems, Foster City, CA, 
USA) and 0.25µl of each probe diluted to 20x (Applied Biosystems, Foster City, CA, USA). A negative control 
(water) was included in each analysis and the thermal cycler was programmed to perform 50 cycles. 
 
Statistical Analysis 
The data were expressed in descriptive measures (average and standard deviation, minimum and 
maximum) and absolute and relative frequency distributions. The probing depth (PD), Clinical attachment 
level (CAL), bleeding on probing, plaque index, age, income and time with diabetes were applied to the Mann-
Whitney non-parametric test to verify associations with the VDR genotype and OHIP. The likelihood ratio 
test was applied for categorical variables when Pearson’s chi-square test and Fisher's exact test could not be 
applied to check variable dependencies. The level of significance adopted was 5%. The software used was SPSS 
20.0. 
 
Ethical Aspects 
The present research was carried out in accordance with the ethical norms established by the Brazilian 
legislation and obtained a favorable verdict for its execution by the Research Ethics Committee of the Federal 
University of Pernambuco and the Hospital Agamenon Magalhães, being registered in the CAAE: 
49166415.0.0000.5208 and the CAAE: 49166415.0.3001.5197, respectively. 
 
Results 
Table 1 describes the clinical-epidemiological profile of the sample studied and its relationship with 
the VDR genotypes. The only variable to have a positive association between genotypes was the mean PD for 
individuals with GG and GA (p=0.023). 
 
Table 1. Descriptive measures of some epidemiological variables and clinical characteristics according 
to the genotypes of VDR (Fok l) rs229570. 
Variables VDR N Mean SD Minimum Maximum p-value 
Age GG 30 60.4 9.6 44.0 80.0 Reference 
 
GA 25 56.9 10.7 20.0 70.0 0.374 
 
AA 3 55.7 7.1 48.0 62.0 0.346 
 
Total 58 58.6 10.1 20.0 80.0 
 
Income (Wages) GG 28 1.2 0.6 0.0 2.2 Reference 
 
GA 23 1.2 0.4 0.5 2.0 0.830 
 
AA 3 2.4 1.7 1.0 4.3 0.134 
 
Total 54 1.3 0.7 0.0 4.3 
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How Long Diabetic GG 26 10.8 8.4 0.0 37.0 Reference 
 
GA 23 13.4 8.2 3.0 30.0 0.227 
 
AA 3 19.0 6.1 12.0 23.0 0.056 
 
Total 52 12.4 8.3 0.0 37.0 
 
Mean PD GG 30 2.7 0.9 1.4 5.2 Reference 
 
GA 25 2.2 0.4 1.3 2.9 0.023* 
 
AA 3 2.2 0.7 1.7 3.0 0.316 
 
Total 58 2.5 0.7 1.3 5.2 
 
Mean CAL GG 30 4.6 2.0 1.6 10.2 Reference 
 
GA 25 3.9 1.6 1.8 7.8 0.250 
 
AA 3 4.1 1.6 2.4 5.3 0.802 
 
Total 58 4.3 1.8 1.6 10.2 
 
Bleeding Index (%) GG 30 15.9 16.0 0.0 50.0 Reference 
 
GA 25 11.6 9.1 0.0 28.1 0.709 
 
AA 3 9.3 9.2 2.3 19.7 0.637 
 
Total 58 13.7 13.2 0.0 50.0 
 
Plaque Index (%) GG 30 25.7 28.4 0.0 100.0 Reference 
 
GA 25 26.5 26.4 0.0 100.0 0.641 
 
AA 3 57.1 37.4 31.8 100.0 0.077 
 
Total 58 27.7 28.3 0.0 100.0 
 
Mann-Whitney non-parametric test; *Statistically significant; p-value comparing each genotype with the reference value in the groups. 
 
Table 2 compares the severity of the periodontal condition in relation to the VDR (Fok l) rs229570 
genotypes, indicating that these genotypes have no positive association with severity (p=0.810). However, the 
data suggests that there is a relationship between genotypes and the extent of periodontitis (p=0.012). While 
in the genotypes GG (96.7%) and GA (80%) the majority had an extension of generalized periodontitis, in 
genotype AA, only 33.3% of the sample demonstrated this clinical characteristic. 
 
Table 2. Absolute and relative frequency of the severity of the periodontal condition in relation to the 
VDR (Fok l) rs229570 genotypes. 
Severity of Periodontal 
Condition 
VDR (Fok l) rs229570 
Total  
GG GA AA p-value 
N % N % N % N % 
 
Severity of Periodontitis 
         
Light 4 13.3 6 24.0 1 33.3 11 19.0 0.810 
Moderate 12 40.0 10 40.0 1 33.3 23 39.7 
 
Severe 14 46.7 9 36.0 1 33.3 24 41.4 
 
Periodontitis Extension 
         
Localized 1 3.3 5 20.0 2 66.7 8 13.8 0.012* 
Generalized 29 96.7 20 80.0 1 33.3 50 86.2 
 
Total 30 100 25 100 3 100 58 100 
 
Likelihood Ratio Test, *Statistically Significant. 
 
In Table 3, the dimensions of OHIP-14 did not show a positive association with the severity of 
periodontitis (p>0.05). 
 
Table 3. Absolute and relative frequency of OHIP-14 dimensions to periodontitis severity. 
 
Severity of Periodontitis 
 
p-valor OHIP Light Moderate Severe Total 
 
N % N % N % N % 
Functional Limitation 
         
No 8 66.7 21 91.3 20 83.3 49 83.1 0.2011 
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Yes 4 33.3 2 8.7 4 16.7 10 16.9 
 
Physical Pain 
         
No 5 41.7 19 82.6 16 66.7 40 67.8 0.0481* 
Yes 7 58.3 4 17.4 8 33.3 19 32.2 
 
Psychological Discomfort 
         
No 7 58.3 18 78.3 14 58.3 39 66.1 0.2881 
Yes 5 41.7 5 21.7 10 41.7 20 33.9 
 
Physical Disability 
         
No 8 66.7 18 78.3 17 70.8 43 72.9 0.7331 
Yes 4 33.3 5 21.7 7 29.2 16 27.1 
 
Psychological Disability 
         
No 7 58.3 19 82.6 18 75.0 44 74.6 0.2931 
Yes 5 41.7 4 17.4 6 25.0 15 25.4 
 
Social Disability 
         
No 10 83.3 23 100.0 22 91.7 55 93.2 0.0972 
Yes 2 16.7 0 0.0 2 8.3 4 6.8 
 
Handcap 
         
No 9 75.0 21 91.3 20 83.3 50 84.7 0.4312 
Yes 3 25.0 2 8.7 4 16.7 9 15.3 
 
Total 12 100.0 23 100.0 24 100.0 59 100.0 
 
1Pearson’s chi-square test; 2Likelihood Ratio Test, *Statistically Significant. 
 
About the OHIP-14 questionnaire, 55.9% of the interviewees had some impact on quality of life, in 
which the dimensions most frequently were: OHIP3 (Psychological Discomfort) and OHIP2 (Physical Pain), as 
shown in Figure 1. 
 
Figure 1. Percentage of the presence of impact on OHIP and its 7 dimensions. 
 
Table 4 shows no positive association between the dimensions of the OHIP-14 and the severity of the 
periodontal condition, as well as the genotypes of the VDR. 
 
Table 4. Absolute and relative frequency of variables: periodontal condition severity and VDR (FokI) 
to the total OHIP-14 impact. 
Variables 
Total OHIP 
Total 
p-value No Impact With Impact 
N % N % N % 
Severity of Periodontitis 
       
Light 3 11.5 9 27.3 12 20.3 0.0901 
Moderate 14 53.8 9 27.3 23 39.0 
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Severe 9 34.6 15 45.5 24 40.7 
 
Total 26 100.0 33 100.0 59 100.0 
 
Periodontitis Extension 
       
Localized 3 11.5 6 18.2 9 15.3 0.7182 
Generalized 23 88.5 27 81.8 50 84.7 
 
Total 26 100.0 33 100.0 59 100.0 
 
VDR 
       
GG 12 46.2 18 56.3 30 51.7 0.6173 
GA 13 50.0 12 37.5 25 43.1 
 
AA 1 3.8 2 6.3 3 5.2 
 
Total 26 100.0 32 100.0 58 100.0 
 
1Pearson’s chi-square test; 2Fisher’s exact test; 3Likelihood Ratio Test. 
 
Discussion 
DM2 was cataloged as the first epidemic of the 21st century [2]. The prevalence, progression and 
severity of DP have been reported as bidirectional and influenced by DM2, which shows an interrelation 
between the two diseases [25]. 
The VDR gene polymorphisms are members of the nuclear receptor superfamily and act as a ligand-
dependent transcription factor [26]. Its alterations in the signaling pathways can lead to different cellular 
defects that are important in the activation of genes, such as the increase or decrease in the transcription of 
calcium metabolism, cell proliferation and immune response [27]. 
The VDR gene is located on chromosome 12q13.11 and is composed of 11 exons [28]. There are 
numerous nucleotide polymorphisms (SNPs) in the VDR gene. BsmI (rs1544410), ApaI (rs7975232), TaqI 
(rs731236) and FokI (rs2228570), are the SNPs most frequently investigated, being associated with 
susceptibility to many cardiovascular diseases, metabolic disorders, cancer, infectious, autoimmune diseases and 
diabetes [29]. 
Despite the previous associations for FokI variants with the risk of developing PD in other 
populations [30,31], increasing its frequency according to the severity of the periodontal condition [32], no 
significant differences were observed between the groups of our sample. Our results corroborate with other 
findings in the literature [9,13] where there was no influence of the FokI polymorphism (rs2228570) on 
chronic periodontitis among the different frequencies of genotypes, alleles, haplotypes and in most clinical 
characteristics. However, there is a statistical difference found in our study regarding the extent of DP and the 
different associated genotypes. 
It is now known that FOKI genotypic variations interact differently with immunospecific 
transcription factors reflecting a variable immune behavior of macrophages, cytokines, dendritic cells and 
lymphocytes [33]. Thus, it is likely that individuals with a VDR FokI polymorphism and different genotypes 
may have different risks for developing autoimmune disorders, which may explain our findings about the 
difference in the extent of periodontitis in the GG, GA and AA genotypes [5]. PD being the result not only of 
an imbalance between the load of periodontopathic bacteria in the subgingival microenvironment and the 
host’s immunological potential [34], but a genetic susceptibility determined by the genotypes [35]. 
The different associations about the influence of FokI on clinical characteristics and severity in 
previous studies can be explained by the genetic configuration of the population sample, where a high degree of 
miscegenation will imply genetic heterogeneity, leading to negative or positive results from the FokI 
interrelation and chronic periodontitis [36]. 
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The dimensions of OHIP-14 in this study did not show positive associations with the severity of 
periodontitis, contrary to other findings [37,38]. And, although patients have reported some impact on quality 
of life, this perception can be explained by the fact that the oral condition is secondary in detriment of the 
systemic, and this fact is evidenced by another study [39]. 
In our study, the dimensions of the OHIP-14 most cited were psychological discomfort, physical pain, 
and physical disability, which, in turn, converges with other studies [38,40], significantly impacting 
individuals' functional limitation [14]. 
The results discussed so far reveal the need to understand the degree of dissatisfaction with the oral 
health of patients with DM2 and chronic periodontitis through OHIP-14, as self-perception in oral health is a 
measure that contributes to the evaluation of care in health generating subsidies to intervene in the health-
disease process [15].  
The limitations identified in this study were the small sample size and the convenience sampling 
method used, which may present a sampling bias that may not be valid to represent the general study 
population. 
 
Conclusion 
The VDR polymorphism in this study had no positive association with the severity and clinical 
characteristics of periodontal disease, but suggested a relationship with the disease's extent. The perception of 
the quality of life of patients with chronic periodontitis and DM2 was compromised by the systemic condition, 
while oral health was secondary, although some dimensions of OHIP-14 have been mentioned more, such as 
psychological discomfort, physical pain and physical disability. Further studies on FokI need to be carried out 
to better clarify its influence on the extent of periodontitis and clinical variables. 
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